BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32714075)

  • 1. Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease.
    Zhang X; Fan Y; Luo Y; Jin L; Li S
    Int J Med Sci; 2020; 17(12):1723-1732. PubMed ID: 32714075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association between major depressive disorder and type 2 diabetes mellitus: Shared pathways and protein networks.
    Liu D; McIntyre RS; Li R; Yang M; Xue Y; Cao B
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110339. PubMed ID: 33915220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
    Wang Y; Wang Z
    Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Communal Molecular Mechanism and Potential Therapeutic Targets in Heart Failure and Type 2 Diabetes Mellitus.
    Wang Z; Gu Y; Sun Y; Xu Y; Zhang M; Jiang T
    Int J Gen Med; 2021; 14():6549-6561. PubMed ID: 34675622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.
    Bao J; Chang W; Zhao Y
    J Mol Neurosci; 2022 Sep; 72(9):1809-1819. PubMed ID: 35731466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling predicts pathways and genes associated with Parkinson's disease.
    Liu S; Zhang Y; Bian H; Li X
    Neurol Sci; 2016 Jan; 37(1):73-79. PubMed ID: 26269422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the shared gene signatures and pathways between sarcopenia and type 2 diabetes mellitus.
    Huang S; Xiang C; Song Y
    PLoS One; 2022; 17(3):e0265221. PubMed ID: 35271662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and pathways in type 2 diabetes mellitus and vitamin C metabolism through bioinformatics analysis.
    Chen C; Han M; Zhang W; Cui J; Cui N; Cao L; Luo G; Sun J
    Asia Pac J Clin Nutr; 2021 Dec; 30(4):715-729. PubMed ID: 34967200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis.
    Lu Y; Li Y; Li G; Lu H
    Mol Med Rep; 2020 Sep; 22(3):1868-1882. PubMed ID: 32705173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of common molecular diagnostic biomarkers between chronic periodontitis and Parkinson's disease via bioinformatics analyses.
    Zehui W; Mengting Z; Pengfei L; Yuanyin W; Jianguang X; Tao W
    J Periodontal Res; 2023 Dec; 58(6):1212-1222. PubMed ID: 37664910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The key genes underlying pathophysiology association between the type 2-diabetic and colorectal cancer.
    Peng WF; Bai F; Shao K; Shen LS; Li HH; Huang S
    J Cell Physiol; 2018 Nov; 233(11):8551-8557. PubMed ID: 29319171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis.
    Zhu Y; Ding X; She Z; Bai X; Nie Z; Wang F; Wang F; Geng X
    Curr Alzheimer Res; 2020; 17(6):566-575. PubMed ID: 32781959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Parkinson's disease-related pathways and potential risk factors.
    Shen J; Chen XC; Li WJ; Han Q; Chen C; Lu JM; Zheng JY; Xue SR
    J Int Med Res; 2020 Oct; 48(10):300060520957197. PubMed ID: 33021140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of gene expression in rats with spinal cord injury based on microarray data.
    Chen G; Fang X; Yu M
    Mol Med Rep; 2015 Aug; 12(2):2465-72. PubMed ID: 25936407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics-based identification of key candidate genes and signaling pathways in patients with Parkinson's disease and obstructive sleep apnea.
    Tang H; Zhang K; Zhang C; Zheng K; Gui L; Yan B
    Sleep Breath; 2024 Jun; 28(3):1477-1489. PubMed ID: 38316731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Cluster Analysis of Protein-Protein Interaction Network-Identified Biomarker for Type 2 Diabetes.
    Li Z; Qiao Z; Zheng W; Ma W
    Diabetes Technol Ther; 2015 Jul; 17(7):475-81. PubMed ID: 25879401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis.
    Yang X; Wang Z
    Medicine (Baltimore); 2023 Aug; 102(31):e34456. PubMed ID: 37543820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.